^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    GenomicsNext™ Liquid Biopsy

    Company:
    Genecentric
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    GenomicsNext™ is GeneCentric Therapeutics’ innovative liquid biopsy platform that uniquely combines high-fidelity DNA variant detection and comprehensive gene expression profiling—all from a single circulating tumor DNA (ctDNA) sample. This enables deeper biomarker insights for precision oncology
    Gene:
    CD31 (Platelet and endothelial cell adhesion molecule 1), EGFR (Epidermal growth factor receptor), GATA3 (GATA binding protein 3), HER-2 (Human epidermal growth factor receptor 2), HRD (Homologous Recombination Deficiency), MET (MET proto-oncogene, receptor tyrosine kinase)
    See More ...
    Method:
    DNA-based molecular screening test